Etiket: Exscientias
Blood Cancer Discovery – Journal further evaluates Exscientia’s precision medicine AI platform to improve patient outcomes
shares in this article Exscientia (Nasdaq: EXAI), ETH Zurich, the Medical University of Vienna and the Center for Molecular Medicine (CeMM) of the Austrian Academy of Sciences today announced a…